Active substanceTetrisolinTetrisolin
Similar drugsTo uncover
  • Vizin® Classic
    drops d / eye 
  • Vizin® Classic
    drops d / eye 
  • VisOptic
    drops d / eye 
  • Montevizin®
    drops d / eye 
    Hemofarm AD     Serbia
  • Octylium
    drops d / eye 
    SIIFI SpA     Italy
  • Dosage form: & nbspeye drops
    Composition:

    Active substance: tetrisisoline hydrochloride 0.5 mg / ml (0.05%);

    Excipients: boric acid, sodium chloride, disodium edetate, benzalkonium chloride solution 17%, sodium borate, purified water.

    Description:A clear, colorless solution.
    Pharmacotherapeutic group:Alpha-adrenomimetic
    ATX: & nbsp

    S.01.G.A.02   Tetrisolin

    Pharmacodynamics:
    Tetrizolin is a sympathomimetic drug that stimulates the alpha-adrenergic receptors of the sympathetic nervous system, but does not or has little effect on beta-adrenergic receptors. Being a sympathomimetic amine, tetrisolin has a vasoconstrictive effect and reduces edema of tissues.The effect begins 60 seconds after instillation and lasts 4-8 hours.
    Pharmacokinetics:

    With topical application is almost not absorbed. Detailed pharmacokinetic studies after topical application of eye drops were not performed.

    Indications:

    Adults and children over 2 years of age are prescribed to relieve edema and congestion of the conjunctiva (reddening of the eyes) arising from allergies or due to chemical and physical factors (smoke, dust, chlorinated water, light, cosmetic products, contact lenses).

    Children under the age of 6 years are appointed under the supervision of a doctor.

    Contraindications:

    Children under 2 years.

    The drug "Vizin" should not be prescribed to patients with increased sensitivity to the components of the drug, patients with closed-angle glaucoma and endothelial-epithelial dystrophy of the cornea.

    Carefully:

    In patients with severe cardiovascular diseases (coronary heart disease, arterial hypertension, arrhythmia, aneurysm), hyperthyroidism, pheochromocytoma, diabetes mellitus and in patients receiving monoamine oxidase inhibitors or other agents capable of increasing blood pressure.

    Pregnancy and lactation:

    Given the risk of general reactions, the drug can be used during pregnancy and lactation only if, in the opinion of the doctor, the perceived benefit exceeds the possible risk.

    Dosing and Administration:

    1 or 2 drops in the affected eye 2-3 times a day.

    It is not recommended continuous use of the drug for more than 4 days.

    Using a vial of a dropper

    Remove the lid from the dropper and flip the bottle.

    Do not touch the tip of the bottle before any surfaces.

    After application, screw the cap of the dropper bottle.

    Side effects:

    With the use of the drug "Vizin" in rare cases, there may be a burning sensation, redness of the eyes, pain in the eye, tingling in the eye, blurred vision, irritation of the conjunctiva and dilated pupil. If these symptoms occur, consult a doctor.

    Overdose:

    When used in accordance with the instructions, the risk of overdose is minimal. However, in case of an inadvertent ingestion into the gastrointestinal tract (GI tract), the following symptoms of an overdose are possible: the dilatation of the pupil, nausea, cyanosis, fever, convulsions, tachycardia, cardiac arrhythmia, cardiac arrest, increased blood pressure, pulmonary edema, respiratory disorders, central nervous system and coma.

    The risk of overdose symptoms associated with drug absorption is high in newborns and young children, especially if swallowed.

    The antidote of tetrisoline hydrochloride is unknown.

    When an overdose is prescribed Activated carbon, gastric lavage, inhalation with oxygen, antipyretic and anticonvulsants. To reduce blood pressure apply phentolamine 5 mg on physiological solution slowly intravenously or 100 mg orally. Patients with low arterial pressure vasopressor agents are contraindicated.

    If any symptoms of an overdose occur, consult a doctor immediately!

    Interaction:Not studied.
    Special instructions:
    Contact lenses should be removed before instillation of the drug and set them in about 15 minutes.

    The drug "Vizin®" should be used only with slight eye irritation. If within 48 hours the condition does not improve or if irritation and redness persist or build up, you should cancel the drug and consult a doctor. If you have intense pain in the eyes, headache, loss of vision, sudden appearance of "floating" spots before your eyes, redness of the eyes, pain when exposed to light or doubling in the eyes, you should immediately consult a doctor.

    Do not use Vizin® if irritation or redness is associated with serious eye diseases: infection, foreign body, or chemical injury to the cornea.

    If the medicine has become unusable or the expiration date has expired, do not throw it into the waste water and throw it out! Place the drug in a bag and put it in the trash. These measures will help protect the environment!

    Effect on the ability to drive transp. cf. and fur:In rare cases, after the application of eye drops "Vizin" there is a dilated pupil and there is a blurred vision, which can affect the ability to drive and machinery.
    Form release / dosage:

    Eye drops 0.05%.

    Packaging:For 15 ml of the drug in a plastic bottle with a drip device and a screw cap with a polypropylene tape - the first opening control. One bottle with instructions for use in a cardboard pack.
    Storage conditions:

    Store at a temperature not exceeding 30 ° C. Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use the product after the expiry date printed on the package!

    The contents of the open vial should be used within 4 weeks.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N013621 / 01
    Date of registration:02.04.2008
    Expiration Date:Unlimited
    The owner of the registration certificate:Johnson & Johnson, LLC Johnson & Johnson, LLC Russia
    Manufacturer: & nbsp
    Representation: & nbspJohnson & Johnson LLC Johnson & Johnson LLC Russia
    Information update date: & nbsp13.02.2017
    Illustrated instructions
      Instructions
      Up